153 related articles for article (PubMed ID: 36763251)
1. Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27.
Remthangpuii F; Maheshwari A; Gulati S; Sharma S; Mahto D; Chandra J
Indian J Pediatr; 2023 Dec; 90(12):1177-1181. PubMed ID: 36763251
[TBL] [Abstract][Full Text] [Related]
2. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.
Nordal EB; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Peltoniemi S; Straume B; Rygg M
Ann Rheum Dis; 2012 Jul; 71(7):1122-7. PubMed ID: 22258487
[TBL] [Abstract][Full Text] [Related]
3. Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis.
McErlane F; Beresford MW; Baildam EM; Chieng SE; Davidson JE; Foster HE; Gardner-Medwin J; Lunt M; Wedderburn LR; Thomson W; Hyrich KL;
Ann Rheum Dis; 2013 Dec; 72(12):1983-8. PubMed ID: 23256951
[TBL] [Abstract][Full Text] [Related]
4. Measurement of blood calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis.
Bojko J
Reumatologia; 2017; 55(1):10-14. PubMed ID: 28386137
[TBL] [Abstract][Full Text] [Related]
5. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.
Sener S; Aliyev E; Batu ED; Balik Z; Bayindir Y; Cam V; Basaran O; Bilginer Y; Ozen S
Clin Rheumatol; 2024 Jun; 43(6):2021-2026. PubMed ID: 38683443
[TBL] [Abstract][Full Text] [Related]
6. Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
Shady MM; Fathy HA; Ali A; Youness ER; Fathy GA
J Pediatr (Rio J); 2015; 91(4):352-7. PubMed ID: 25727025
[TBL] [Abstract][Full Text] [Related]
7. Physical activity, functional ability, and disease activity in children and adolescents with juvenile idiopathic arthritis.
Gueddari S; Amine B; Rostom S; Badri D; Mawani N; Ezzahri M; Moussa F; Shyen S; Abouqal R; Chkirat B; Hajjaj-Hassouni N
Clin Rheumatol; 2014 Sep; 33(9):1289-94. PubMed ID: 24651917
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status.
El Gazzar II; Fathy HM; Gheita TA; Nour El-Din AM; Rasheed EA; Bassyouni RH; Kenawy SA
Clin Rheumatol; 2017 Aug; 36(8):1757-1763. PubMed ID: 28593608
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a composite disease activity score for juvenile idiopathic arthritis.
Consolaro A; Ruperto N; Bazso A; Pistorio A; Magni-Manzoni S; Filocamo G; Malattia C; Viola S; Martini A; Ravelli A;
Arthritis Rheum; 2009 May; 61(5):658-66. PubMed ID: 19405003
[TBL] [Abstract][Full Text] [Related]
10. Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.
Fotis L; Shaikh N; Baszis KW; Samson CM; Lev-Tzion R; French AR; Tarr PI
J Rheumatol; 2017 Nov; 44(11):1624-1631. PubMed ID: 28916545
[TBL] [Abstract][Full Text] [Related]
11. Uric acid could be a marker of cardiometabolic risk and disease severity in children with juvenile idiopathic arthritis.
Gicchino MF; Marzuillo P; Zarrilli S; Melone R; Guarino S; Miraglia Del Giudice E; Olivieri AN; Di Sessa A
Eur J Pediatr; 2023 Jan; 182(1):149-154. PubMed ID: 36229695
[TBL] [Abstract][Full Text] [Related]
12. The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study.
d'Angelo DM; Attanasi M; Di Donato G; Lapergola G; Flacco M; Chiarelli F; Altobelli E; Breda L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675189
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
Brunner HI; Tzaribachev N; Vega-Cornejo G; Louw I; Berman A; Calvo Penadés I; Antón J; Ávila-Zapata F; Cuttica R; Horneff G; Foeldvari I; Keltsev V; Kingsbury DJ; Viola DO; Joos R; Lauwerys B; Paz Gastañaga ME; Rama ME; Wouters C; Bohnsack J; Breedt J; Fischbach M; Lutz T; Minden K; Miraval T; Ally MMTM; Rubio-Pérez N; Solau Gervais E; van Zyl R; Li X; Nys M; Wong R; Banerjee S; Lovell DJ; Martini A; Ruperto N;
Arthritis Rheumatol; 2018 Jul; 70(7):1144-1154. PubMed ID: 29481737
[TBL] [Abstract][Full Text] [Related]
14. Association of hand grip strength with disease activity, disability and quality of life in children and adolescents with Juvenile Idiopathic Arthritis.
Rashed AM; Abdel-Wahab N; Moussa EMM; Hammam N
Adv Rheumatol; 2018 Jun; 58(1):11. PubMed ID: 30657067
[TBL] [Abstract][Full Text] [Related]
15. Serum calprotectin (S100A8/9), clinical and ultrasound assessment in patients with juvenile idiopathic arthritis.
Romano M; Gerloni V; De Lucia O; Piskin D; Giani T; Gattinara M; Borghi MO; Bodio C; Mahler M; Meroni PL; Cimaz R
Clin Exp Rheumatol; 2021; 39(5):1132-1140. PubMed ID: 34128789
[TBL] [Abstract][Full Text] [Related]
16. The dual role of body mass index on Juvenile Idiopathic Arthritis course: a pediatric experience.
Gicchino MF; Marzuillo P; Melone R; Zarrilli S; Miraglia Del Giudice E; Olivieri AN; Di Sessa A
Eur J Pediatr; 2024 Feb; 183(2):809-813. PubMed ID: 38015262
[TBL] [Abstract][Full Text] [Related]
17. Strong relationships between disease activity, foot-related impairments, activity limitations and participation restrictions in children with juvenile idiopathic arthritis.
Dekker M; Hoeksma AF; Dekker JH; van Rossum MA; Dolman KM; Beckerman H; Roorda LD
Clin Exp Rheumatol; 2010; 28(6):905-11. PubMed ID: 21122275
[TBL] [Abstract][Full Text] [Related]
18. Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis.
Heale LD; Houghton KM; Rezaei E; Baxter-Jones ADG; Tupper SM; Muhajarine N; Benseler SM; Boire G; Cabral DA; Campillo S; Chédeville G; Chetaille AL; Dancey P; Duffy C; Duffy KW; Ellsworth J; Guzman J; Huber AM; Jurencak R; Lang B; Laxer RM; Morishita K; Oen KG; Petty RE; Ramsey SE; Roth J; Schneider R; Scuccimarri R; Spiegel L; Stringer E; Tse SML; Tucker LB; Turvey SE; Yeung RSM; Rosenberg AM;
Pediatr Rheumatol Online J; 2021 Jun; 19(1):97. PubMed ID: 34187498
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis.
Bulatović Calasan M; de Vries LD; Vastert SJ; Heijstek MW; Wulffraat NM
Rheumatology (Oxford); 2014 Feb; 53(2):307-12. PubMed ID: 24162034
[TBL] [Abstract][Full Text] [Related]
20. Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value-a single-center study.
Lipinska J; Kaszkowiak M; Malachowska B; Swidrowska-Jaros J; Smolewska E
Arthritis Res Ther; 2021 Jan; 23(1):40. PubMed ID: 33494811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
